Log in
Enquire now
Umoja Biopharma

Umoja Biopharma

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
‌
Andrew Scharenberg, MD
CFO
‌
Britton Russell
Company Operating Status
Active
COO
‌
David Fontana, PhD
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...iopharma
CTO
‌
Ryan Crisman, PhD
Email Address
info@umoja-biopharma.com
Founded Date
2019
Founder
‌
Andrew Scharenberg, MD
Full Address
1920 Terry Avenue, Seattle, WA 98101, US
Industry
Cell therapy
Cell therapy
Biomedical engineering
Biomedical engineering
Healthcare
Healthcare
Regenerative medicine
Regenerative medicine
Biotechnology
Biotechnology
Stem cell
Stem cell
Pharmaceutical industry
Pharmaceutical industry
Tissue engineering
Tissue engineering
Immunotherapy
Immunotherapy
Engineering
Engineering
•••
Investors
MPM Capital
MPM Capital
Qiming Venture Partners (USA)
Qiming Venture Partners (USA)
Latest Funding Round Date
June 2021
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/umoja-biopharma
Location
Seattle
Seattle
Number of Employees (Ranges)
51 – 200
Public/Private
Private
Total Funding Amount (USD)
262,969,286
Twitter URL
@UmojaBiopharma
Official Website
umoja-biopharma.com

Find more companies like Umoja Biopharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us